Aberrant Methylation of Thrombospondin-1 and Its Association with Reduced Expression in Gastric Cardia Adenocarcinoma

<table>The concentration of total and active TGF-<svg height="13.55" id="M145" style="vertical-align:-2.29482pt" version="1.1" viewbox="0 0 16.6625 13.55" width="16.6625" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,13.55)">
<g transform="translate(72,-61.16)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝛽</tspan>
<tspan style="font-size: 12.50px; " x="6.9641709" y="0">1</tspan>
</text>
</g>
</g>
</svg> in different groups. 1: healthy controls, 2: GCA patients, 3: GCA patients with TSP1 methylation, 4: GCA patients without TSP1 methylation, 5: stage I and II GCA patients, 6: stage III and IV GCA patients.</table>

BioMed Research International

fig4

Figure 4

Figure 4: Aberrant Methylation of Thrombospondin-1 and Its Association with Reduced Expression in Gastric Cardia Adenocarcinoma 